Evidence map›Paper›PMID 39616153›Full record

ArticleCell discovery2024

Structural insights into physiological activation and antagonism of melanin-concentrating hormone receptor MCHR1.

Xiaofan Ye, Guibing Liu, Xiu Li, Binbin He, Yuyong Tao, Jiasheng Guan, Yuguang Mu, Haiping Liu, Weimin Gong

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell discovery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xiaofan Ye *Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.ORCID http://orcid.org/0009-0008-6388-0873
Guibing Liu *Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.ORCID http://orcid.org/0009-0005-7555-0167
Xiu LiDivision of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
Binbin HeDivision of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
Yuyong TaoDivision of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.ORCID http://orcid.org/0000-0002-9257-1438
Jiasheng GuanDivision of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
Yuguang MuDivision of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China. ygmu@ntu.edu.sg.
Haiping LiuDivision of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China. haipingliu@ustc.edu.cn.
Weimin GongDivision of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China. wgong@ustc.edu.cn.

Funding

Ministry of Science and Technology of the People's Republic of China (Chinese Ministry of Science and Technology) 2021YFA0910202National Natural Science Foundation of China (National Science Foundation of China) T2221005University of Chinese Academy of Sciences (Graduate University of Chinese Academy of Sciences) XDB0540000
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39616153
PMCPMC11608246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.